Parkinson's: Why Has Disease Modification Failed — And What Now?
Source: Premier Research

Researchers have made many attempts at disease modification as they pursue breakthroughs in treating Parkinson’s disease, but so far without success. Why have these efforts failed, and what’s next in treating this degenerative disorder that affects an estimated 10 million people worldwide?
We tackled these questions in a Premier Research webcast, The Potential for Disease Modifying Therapies in Parkinson’s Disease. In this blog post, the second of three on the subject, we examine these past attempts, why they failed, and what targets are currently being pursued.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
Premier Research
This website uses cookies to ensure you get the best experience on our website. Learn more